Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,722 | -7,765 | -5,539 | -6,515 | -12,649 |
| Depreciation Amortization | 1,916 | 1,338 | 678 | 2,724 | 1,808 |
| Accounts receivable | -14,957 | -5,654 | -10,799 | -7,099 | -3,606 |
| Accounts payable and accrued liabilities | 4,669 | 507 | 4,137 | 5,164 | 1,518 |
| Other Working Capital | -9,603 | -7,909 | -8,562 | -6,811 | -3,167 |
| Other Operating Activity | 15,212 | 8,301 | 8,095 | -4,785 | 5,936 |
| Operating Cash Flow | $-9,485 | $-11,182 | $-11,990 | $-17,322 | $-10,160 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 5,000 | 5,000 |
| PPE Investments | 1,226 | 1,396 | -391 | 6,646 | 6,974 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -40 | -40 |
| Other Investing Activity | 0 | 0 | 0 | -40 | -40 |
| Investing Cash Flow | $1,226 | $1,396 | $-391 | $11,606 | $11,934 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 15,000 | N/A | N/A | N/A |
| Common Stock Issued | 8,455 | 8,265 | 8,135 | 7,588 | 366 |
| Other Financing Activity | -1,213 | -1,199 | -408 | -543 | -543 |
| Financing Cash Flow | $22,242 | $22,066 | $7,727 | $7,045 | $-177 |
| Exchange Rate Effect | -1 | -1 | N/A | 1 | 1 |
| Beginning Cash Position | 27,892 | 27,892 | 27,892 | 26,562 | 26,562 |
| End Cash Position | 41,874 | 40,171 | 23,238 | 27,892 | 28,160 |
| Net Cash Flow | $13,982 | $12,279 | $-4,654 | $1,330 | $1,598 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,485 | -11,182 | -11,990 | -17,322 | -10,160 |
| Capital Expenditure | -1,274 | -1,104 | -391 | -854 | -526 |
| Free Cash Flow | -10,759 | -12,286 | -12,381 | -18,176 | -10,686 |